Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT04844008

Do Nanobubbles Improve Joint Hypoxia?

An Investigation of Whether Orally Delivered Nanobubbles Have a Physiological Effect on Joint Hypoxia?

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
University of Oxford · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Inflamed joints in patients with rheumatoid arthritis and psoriatic arthritis are characterized by low oxygen levels and inflammation. We propose to investigate whether tiny bubbles (nanobubbles) when given in a drink can alter oxygen level in joints. These nanobubbles are so small that they can enter the bloodstream when given as a drink. This information will give new information on the role of oxygen in joint inflammation and could possibly lead to new treatment approaches in the future.

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTNanobubble drinkCommercially available sports drink

Timeline

Start date
2021-10-05
Primary completion
2022-05-17
Completion
2022-05-17
First posted
2021-04-14
Last updated
2022-05-24

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT04844008. Inclusion in this directory is not an endorsement.